C-terminal-binding protein-2 (Ctbp2)-knockout mice show early embryonic lethality.33In addition, Ctbp2 was identified as a core Oct4-interacting protein in ESCs.34Recently, Ctbp2 was revealed to control the epigenetic states of H3K27 in active ESC genes by interconnecting the NuRD complex an...
Completion of a new $56.1 million senior secured term loan commitment to Onward Medical N.V. (Euronext: ONWD) (“Onward”), funding $17.1 million at close. Onward is a medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence ...